Year 2006-2007
|
||
| Name | Protocol Titles | |
| Alexis Dieter | HIV-1 Subtype C Infection: Response to Treatment as a Function of Disease Progression | |
| Kelly Smith | HSV-2 and HIV-1 subtype C set point in a group of women in KwaZulu-Natal, South Africa | |
| Adam Bograd | The Intramural course of anomalous coronary arteries: a high-risk characteristic? | |
| Leif-Erik Bohman | Cell-free DNA in patients with Glioblastoma Multiforme: A Pilot Study | |
| Ellen Goldstein | Basal Cell Carcinoma Chemoprophylaxis with Tazarotene: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial | |
| Jason Harper | Bioavailability of Ferrous Sulfate Versus Ferrous Bis-glycinate in Celiac Disease | |
| Tom Karnezis | Post Prevnar: Changes in Pneumococcal Acute Otitis Media Incidence and in Rates of Penicillin Resistant Pneumococcal Acute Otitis Media | |
| Christopher Kellner | Evaluation of a Revised Scale for the Prediction of Long-Term Outcome in Poor-Grade Aneurysmal Subarachnoid Hemorrhage Undergoing Operative Repair | |
| David Hahn | Retrospective Analysis to Assess the Efficacy of Microsurgical Fenestration of the Lamina Terminalis in Reducing the Incidence of Shunt-Dependent Hydrocephalus following Aneurysmal Subarachnoid Hemorrhage | |
| Anaeze Offodile | Study of the differential effects of minimally invasive and open colorectal resection on post-operative immune function by evaluating the circulating levels of plasma proteins and cytokines | |
| Irene J. Lo | A Transplant Center’s Experience with Orthotopic Liver Transplantation Outside of the Milan Criteria: Is Expansion of Current Allocation Criteria Justified? | |
| Mark Mann | A Combined Phase I and Phase II trial of Abraxane (ABI-007) for BCG-Refractory Superficial Transitional Cell Carcinoma | |
| Matthew O'Rourke | Sensitivity and Specificity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in an Emergency Room Population | |
| Monique Vanaman | Accuracy of Fetal MRI in Diagnosing CNS Anomalies | |
| Scott Henneman | Effects of Local Hypothermia on Neurological Outcome in Acute Ischemic Stroke | |
| Amie Dave | Everolimus and Temozolimide in pediatric recurrent or progressive high grade-gliomas | |